JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 28 No. 5 871-877
© 1987 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnston, D. L.
Right arrow Articles by Okada, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnston, D. L.
Right arrow Articles by Okada, R. D.

Use of Gadolinium-DTPA as a Myocardial Perfusion Agent: Potential Applications and Limitations for Magnetic Resonance Imaging

Donald L. Johnston, Peter Liu, Randall B. Lauffer, John B. Newell, Van J. Wedeen, Bruce R. Rosen, Thomas J. Brady and Robert D. Okada

Cardiac Unit, Department of Medicine and the Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

Correspondence: For reprints contact: Donald L. Johnston, MD, Dept. of Cardiology, Rm 512 D, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030.

ABSTRACT

To establish the effect of the paramagnetic contrast agent gadolinium diethylenetriaminepentaacetic acid ([Gd]DTPA) on myocardial magnetic resonance relaxation parameters T1 and T2, and its relationship to myocardial perfusion, we administered [Gd] DTPA 0.2 mM/kg to two groups of dogs. Group I had severe, resting myocardial ischemia induced by coronary occlusion, followed in 2 min by [Gd]DTPA infusion and heart excision 1 min later. Group II had a variable reduction in blood flow. In Group II the coronary vasodilator dipyridamole was infused to enhance blood flow to the normal myocardium before [Gd]DTPA was given. In Group I [Gd]DTPA caused a significant difference in T1 between the normal and severely ischemic zones; changes in T1 correlated with the severity of myocardial ischemia. Although vasodilatation delivered more Gd-DTPA to the normal myocardium in Group II, the lack of further decrease in T1 suggested that it was cleared more rapidly. Thus, [Gd]DTPA permits the detection and characterization of severe, resting myocardial ischemia by magnetic resonance techniques. Using the experimental techniques described in this study, less severe flow differences caused by vasodilatation and resultant hyperemia are not detected.




This article has been cited by other articles:


Home page
CirculationHome page
R. J. Kim, E.-L. Chen, J. A.C. Lima, and R. M. Judd
Myocardial Gd-DTPA Kinetics Determine MRI Contrast Enhancement and Reflect the Extent and Severity of Myocardial Injury After Acute Reperfused Infarction
Circulation, December 15, 1996; 94(12): 3318 - 3326.
[Abstract] [Full Text]


Home page
CirculationHome page
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke
Magnetic Resonance Imaging in Coronary Artery Disease
Circulation, November 1, 1995; 92(9): 2723 - 2739.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1987 by the Society of Nuclear Medicine.